Soluble urokinase plasminogen activator receptor: from biomarker to active participant in atherosclerosis and cardiovascular disease

Atherosclerosis contributes to the majority of deaths related to cardiovascular disease (CVD). Recently, the nonspecific inflammatory biomarker soluble urokinase plasminogen activator receptor (suPAR) has shown prognostic value in patients with CVD; however, it remains unclear whether suPAR particip...

Descripción completa

Detalles Bibliográficos
Autores principales: Goodchild, Traci T., Li, Zhen, Lefer, David J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Clinical Investigation 2022
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9754098/
https://www.ncbi.nlm.nih.gov/pubmed/36519539
http://dx.doi.org/10.1172/JCI165868

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9754098/
https://www.ncbi.nlm.nih.gov/pubmed/36519539
http://dx.doi.org/10.1172/JCI165868

Ejemplares similares